Welcome to The IQT Podcast! In this episode, we explore IQT's origin story in biotech. Host Farid Nemri, along with guests Dr. Megan Anderson and Dr. Kevin O'Connell, discuss IQT's strategic investments in the bio sector, spanning from the post-9/11 era to the start of the COVID-19 pandemic. Dive into the history of the B.Next practice, IQT's investing methodology, and the technologies developed for national security and pandemic readiness. Interested in learning more? Tune back in for next week’s episode where we’ll pick up with IQT’s present-day biotech investing strategy.

Featured in this Episode

Farid Nemri

Program Manager

LinkedIn: https://www.linkedin.com/in/faridnemri/

Dr. Megan Anderson

Executive Vice President

LinkedIn: https://www.linkedin.com/in/megan-anderson-408a639/

Dr. Kevin O'Connell

SVP Technology

LinkedIn: https://www.linkedin.com/in/kevin-o-connell-3885695/